Daejeon University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Daejeon Korea, Republic of (1979)

Organization Overview

First Clinical Trial
2008
NCT01270048
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Daejeon Sun Hospital | Daejeon University | Dunsan Korean Medicine Hospital of Daejeon University | Dunsan Korean Medicine Hospital of Daejeon University,Korea | Oriental Hospital of Daejon University

Active Ingredients

Drugs in Phase 4 Trials (3)

collagen (1 trial)

sihogayonggolmoryu tang (1 trial)

sogyeonghwalhyeol-tang (2 trials)

Drugs in Phase 3 Trials (3)

kyungbangn gamisoyosan (1 trial)

mild-x-gwarip (1 trial)

yeongyopaedok-san (1 trial)

Drugs in Phase 2 Trials (2)

gualouhengryunhwan (1 trial)

jaeumgeonbi-tang (1 trial)

Drugs in Other Trials (3)

angelica (1 trial)

cinnamon (1 trial)

cnidium rhizome (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Disease (Phase 2)

Anxiety Disorders (Phase 4)

Back Pain (Phase 4)

Bronchitis (Phase 2)

Communicable Diseases (Phase 3)

Disease (Phase 3)

Fasciitis (Phase 4)

Fasciitis, Plantar (Phase 4)

Infections (Phase 3)

Low Back Pain (Phase 4)

Respiratory Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 11